Responsive neurostimulation · Grey Matter

Responsive neurostimulation is an implanted closed-loop system that records the electrical activity of a seizure focus and stimulates it only when it detects the start of a seizure, and it treats epilepsy in people whose focal seizures resist drugs and cannot be removed by epilepsy surgery.

Responsive neurostimulation. Responsive neurostimulation is an implanted closed-loop system that records the electrical activity of a seizure focus and stimulates it only when it detects the start of a seizure, and it treats epilepsy in people whose focal seizures resist drugs and cannot be removed by epilepsy surgery.

The neurostimulator sits in a recess cut into the skull and connects to one or two leads, each with four contacts, placed at the one or two places where the seizures begin (often the hippocampus on one or both sides). It reads electrocorticography from those contacts all day and runs detectors that the neurologist tunes to the patient's own seizure onset. When a detector fires, the device delivers a short burst of pulses within milliseconds, and the patient feels nothing. It also stores stretches of the recording, which the patient uploads at home, so clinicians see months of epileptiform discharges and seizures they would otherwise never record.

Its benefit grows with time. In the blinded trial behind its approval, seizures fell 37.9 % with stimulation against 17.3 % with sham; after nine years the median reduction was 75 %, and 35 % of patients had at least 90 % fewer seizures.

It can treat both temporal lobes at once, where removing both would destroy memory.

Its recordings are a dataset of their own. Years of intracranial signals from freely living patients have shown that seizure risk follows cycles of days and weeks, and they are neural data held by the patient's clinicians and the company.

Adaptive stimulation brought the same loop to movement disorders. Medtronic's BrainSense adaptive system for Parkinson's disease, approved in the United States in February 2025, keeps deep brain stimulation running continuously and adjusts its strength to a rhythm it senses on the same leads, where responsive neurostimulation stays silent until a seizure starts.

Responsive neurostimulation acts only at the moment a seizure begins.

Listening first and stimulating on demand lets one small device treat a focus that cannot be cut out, and leaves a record of the disease as the patient lives it.

Questions: How does responsive neurostimulation differ from deep brain stimulation for epilepsy? They differ in where they act and when. Deep brain stimulation for epilepsy sits in the anterior nucleus of the thalamus, a hub through which seizures spread, and stimulates on a fixed schedule whatever the brain is doing. Responsive neurostimulation places its leads at the seizure focus itself, records it continuously and stimulates only when it detects a seizure starting, so the team must first know where seizures begin. The thalamic approach suits seizures whose origin is unclear or widespread, and the responsive one suits one or two well-located foci. When do doctors implant a responsive stimulator instead of removing the seizure focus? Removal is preferred when it is safe, because it can stop seizures altogether. A stimulator is chosen when the focus lies in tissue that cannot be spared, such as cortex that controls language or movement, or when seizures start in both hippocampi, where removing both would destroy the ability to form new memories. Responsive stimulation rarely ends seizures entirely, but its effect grows over the years, reaching a median reduction of 75 % after nine years in the long-term study.